|
Market Cap (20-Jun) $15,071,113 (1,218th) |
Close (30-Jun) $6.60 |
Volume (30-Jun) 0 |
Shortsold (31-Aug) 59,797 (0.02%) (544th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -547.5 |
MDC released this announcement to the ASX on 28 June 2021, 16:03. The announcement is not marked as price sensitive, and is 7 page(s) in length and 29.55kb in size.
You can view all announcements from MDC and see how they appear on a price chart on the announcements page.
At the date of this announcement, MDC was 0.018% short sold according to ASIC data. It was ranked the 569th most shorted stock on the ASX. It is now ranked as the 544th most shorted stock on the ASX with 0.017% of total shares short sold as of the latest reported data (31 August 2021).
| Other Recent Announcements from MDC | |
|---|---|
| Medlab Update to Shareholders | 7 June 2023, 10:22 |
| Response to ASX Query | 23 March 2023, 15:45 |
| Medlab Update to Shareholders | 21 March 2023, 10:39 |
| Proposed issue of securities - MDC | 28 June 2021, 16:03 |
| European and Canadian Patent Offices Grant NanoCelle Patents | 23 June 2021, 8:50 |
| Medlab Presenting - LD Micro Invitational XI Conference 2021 | 7 June 2021, 8:30 |
| Addendum to Appendix 4C | 4 June 2021, 15:50 |
You must be logged in to post a reply.
Medlab Clinical 